[HTML][HTML] Unravelling the genetic links between Parkinson's disease and lung cancer

YQ Leong, RY Koh, SM Chye, KY Ng - Biological Chemistry, 2023 - degruyter.com
Increase evidence from epidemiological studies have shown an inverse association
between Parkinson's disease (PD) and lung cancer. PD and lung cancer are both geriatric …

[HTML][HTML] Recent trends of lung cancer in Korea

JG Lee, HC Kim, CM Choi - Tuberculosis and Respiratory Diseases, 2021 - ncbi.nlm.nih.gov
Lung cancer is one of the leading causes of cancer-related deaths in Korea. Although the
smoking rate has decreased over time, the prevalence of lung cancer still remains high. In …

High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy

BW Yoon, B Chang, SH Lee - OncoTargets and therapy, 2020 - Taylor & Francis
Purpose Although programmed death-ligand 1 (PD-L1) expression is widely accepted as a
predictive and prognostic biomarker in immunotherapy, its implications in lung cancer …

NEIL3 mediates lung cancer progression and modulates PI3K/AKT/mTOR signaling: a potential therapeutic target

H Huang, Q Hua - International Journal of Genomics, 2022 - Wiley Online Library
Background. Nei endonuclease VIII‐like 3 (NEIL3) is widely involved in pathophysiological
processes of the body; however, its role in lung cancer has not been conclusively …

[HTML][HTML] Characteristics of the immune cell infiltration landscape in gastric cancer to assistant immunotherapy

C Li, J Pan, Y Jiang, Y Yu, Z Jin, X Chen - Frontiers in genetics, 2022 - frontiersin.org
Background: Gastric cancer (GC) was usually associated with poor prognosis and invalid
therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to …

Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer

M Yotsukura, K Nakagawa, K Suzuki… - Japanese Journal of …, 2021 - academic.oup.com
The superior efficacy of immune checkpoint inhibitors for the treatment of advanced non-
small cell lung cancer has inspired many clinical trials to use immune checkpoint inhibitors …

[HTML][HTML] New targeted therapy for non-small cell lung cancer

EK Chung, SH Yong, EH Lee, EY Kim… - Tuberculosis and …, 2023 - ncbi.nlm.nih.gov
Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men.
More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant …

Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma

IK Hong, JM Lee, IK Hwang, SS Paik… - Cancer management …, 2020 - Taylor & Francis
Purpose The clinical implications of the metabolic parameters of 18F-fluorodeoxyglucose
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …

[HTML][HTML] Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy

C Li, J Pan, J Luo, X Chen - BMC Pulmonary Medicine, 2021 - Springer
Background Non-small cell lung cancer (NSCLC) was usually associated with poor
prognosis and invalid therapeutical response to immunotherapy due to biological …

[HTML][HTML] A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma

Y Guo, G Li, M Xu, B Peng - Computers in Biology and Medicine, 2022 - Elsevier
Accumulating evidence suggests that long noncoding RNAs (lncRNAs) play a critical role in
regulating cancer immunity and the tumor microenvironment. Tumor-infiltrating …